Lv5
830 积分 2023-05-23 加入
Final overall survival analysis and exploratory biomarker study from JUPITER-06: a randomized phase III trial of toripalimab plus chemotherapy in advanced esophageal squamous-cell carcinoma
3天前
已关闭
The TUB variant impairs leptin sensitivity and AgRP neuronal response, leading to obesity
4天前
已完结
Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer
11天前
已关闭
Clinical Outcomes of Immune Checkpoint Inhibitor Therapy in Patients With Advanced Non-small Cell Lung Cancer and Preexisting Interstitial Lung Diseases
17天前
已完结
190P: Real-world 5-year survival outcomes with durvalumab (D) after chemoradiotherapy (CRT) in unresectable, stage III NSCLC (urNSCLC): Final data extraction from PACIFIC-R
25天前
已关闭
Phase I study of biweekly liposome irinotecan (PEP02, MM-398) in metastatic colorectal cancer failed on first-line oxaliplatin-based chemotherapy
25天前
已关闭
Management of Pulmonary Large-Cell Neuroendocrine Carcinoma (LCNEC): An Updated Review
25天前
已完结
Pulmonary neuroendocrine neoplasms: the molecular landscape, therapeutic challenges, and diagnosis and management strategies
25天前
已完结
16-h fasting optimizes cancer immunotherapy in mice and humans
30天前
已完结
Pembrolizumab plus lenvatinib in recurrent gynaecological clear cell carcinoma (LARA): a multicentre, single-arm, phase 2 trial
1个月前
已完结
皖公网安备34019202002308
